Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
TAVR
MedTech
FDA approves Edwards TAVR for patients before they show symptoms
The current standard of care is monitoring the patient with regular check-ups to see if they begin to develop chest pain or shortness of breath.
Conor Hale
May 1, 2025 12:56pm
Edwards highlights 8-year durability data for its Resilia valves
Apr 18, 2025 11:30am
Abbott completes first-in-human balloon-expanded TAVR procedures
Nov 25, 2024 1:30pm
TCT: Boston Scientific's TAVR implant fails head-to-head study
Oct 30, 2024 11:55am
TCT: Using TAVR early helps prevent later hospitalizations
Oct 28, 2024 11:22am
Medtronic expands reach of latest TAVR valve with EU approval
Oct 24, 2024 1:00pm
